WHO and the Cigarette-Shaped Imagination
The WHO’s nicotine pouch report exposes public health’s unresolved problem with harm reduction
The Core Tension
The WHO’s nicotine pouch report is somewhat right about the marketing problem but uneasy about the harm-reduction problem.
It highlights a typical commercial style: playful, vibrant packaging; influencer marketing; sports sponsorships; aspirational branding; and trendy language. It also features flavors, discreet formats, and tobacco-free language. These strategies can lower the symbolic barrier to nicotine use, especially for adolescents and young never-smokers.
But the report struggles with the harder ambiguity: the same attributes that may attract never-users can also help adult smokers move away from cigarettes.
That is the fault line. Nicotine pouches are not harmless. But they are also not combustible cigarettes. Public health can readily recognize the first fact. It still hesitates before the second.
Why It Matters
For decades, tobacco control was organized around a clear enemy: the cigarette. It joined nicotine, combustion, addiction, disease, death, and industry manipulation in a single object.
Nicotine pouches disrupt that clarity. They deliver nicotine without tobacco leaf, without smoke, without smell, and without combustion, the mechanism responsible for most smoking-related harm.
The WHO report responds mainly through the grammar of precaution. That is understandable. Youth uptake matters. Marketing matters. Dependence matters.
But precaution becomes incomplete when it cannot accommodate relative risk.
If public health treats all nicotine products as extensions of the cigarette, it may protect the moral clarity of tobacco control while weakening its capacity to reduce harm among smokers who have not quit.
Evidence at a Glance
The WHO report warns that nicotine pouch marketing is expanding faster than regulation.
Its central concern is commercial capture: flavors, packaging, digital influence, sports sponsorships, and “tobacco-free” branding.
In Great Britain, nicotine pouch use among 16-to-24-year-olds rose from 0.7% in January 2022 to 4.0% in March 2025; among young men, it reached 7.5%.
The same data show overlap with smoking and vaping, making it difficult to reduce the trend to simple initiation.
In the United States, youth pouch use among 10th- and 12th-grade students increased from 2023 to 2024, alongside dual use with e-cigarettes.
The unresolved question is whether growth reflects initiation, experimentation, dual use, substitution, cessation attempts, or all of these at once.
Why This Matters for Policy
Scientific
The key question is not whether nicotine pouches are safe. They are not risk-free. Nothing is.
The key question is: safe compared with what?
Compared with abstinence, pouches carry risk. Compared with combustible cigarettes, the toxicological distance is substantial. The main devastation caused by smoking comes from combustion: tar, carbon monoxide, ultrafine particles, and thousands of toxic compounds generated by burning tobacco.
The WHO report sees absolute risk clearly. It is less comfortable with relative risk.
Regulatory
The report reflects a regulatory imagination still shaped by the cigarette.
That creates a problem. If pouches are regulated only as a youth threat, adult smokers may lose access to lower-risk alternatives. If they are promoted without guardrails, youth uptake may expand.
The task is not to choose one reality and deny the other. It is to regulate by user, product, risk, and context.
That means strict age controls, marketing restrictions, product standards, surveillance, and honest communication about comparative risk.
Equity Implications
The missing figure in much of the WHO’s framing is the persistent adult smoker.
As smoking declines, it becomes more concentrated among people facing psychological distress, low income, precarious work, interrupted schooling, and social exclusion. For many of them, quitting is not simply a matter of information or willpower.
A public-health model that rejects lower-risk alternatives because they fall short of abstinence may leave the most vulnerable smokers with the most harmful product.
Communication
The WHO is right to expose some language of commercial seduction.
But public health also has a language problem of its own. When it refuses to distinguish nicotine from combustion, or lower-risk products from cigarettes, it produces confusion in the name of protection.
And confusion favors the cigarette. When everything is made to sound equally dangerous, the most familiar product keeps its advantage.
The Strategic Question
The question is not: How do we stop nicotine pouches?
The better question is: Can public health prevent youth capture without denying harm reduction to smokers still exposed to combustion?
Recommended Actions
For Regulators & Public-Health Agencies
Separate youth-prevention policy from adult harm-reduction policy.
Regulate marketing, packaging, flavors, age access, nicotine strength, and product quality.
Communicate clearly that lower risk does not mean risk-free.
Monitor initiation, dual use, substitution, cessation attempts, and relapse separately.
Stop treating all nicotine use as morally equivalent to smoking.
For Politics
Do not use precaution as a substitute for proportionality.
Keep combustion at the center of tobacco policy.
Recognize that harm reduction is not surrender; it is a response to the limits of abstinence-only models.
Ask whether restrictions reduce harm or preserve the cigarette’s dominance.
Treat the nicotine policy as a question of inequality, evidence, markets, and risk, not only youth protection.
For Journalists & Opinion Leaders
Avoid turning the report into a simple “new nicotine epidemic” story.
Distinguish initiation, experimentation, dual use, substitution, and cessation.
Keep adult smokers in the frame.
Report marketing risks without collapsing all nicotine products into cigarettes.
Explain the difference between nicotine, tobacco, and combustion.
The Risk of Misreading
This is not a defense of nicotine pouches as harmless products.
It is a critique of a public-health reflex: seeing every new nicotine technology primarily through the moral memory of the cigarette.
The WHO report is strongest when it exposes certain commercial tactics. It is weakest when it treats ambiguity as a regulatory inconvenience rather than as the central fact of the post-cigarette nicotine landscape.
Bottom Line
The WHO can see the danger of nicotine pouches as products of initiation. It still struggles to see their possible role as products of substitution. That is the unresolved public health problem after the cigarette.
